Christopher Whitmore
Geen lopende functies
Profiel
Christopher Whitmore worked as a Senior Director-Finance & Controller at Talphera, Inc. from 2011 to 2015.
Prior to that, he was a Controller at Sangamo Therapeutics, Inc. from 2008 to 2011, and an Audit Manager at KPMG LLP from 2002 to 2008.
He also held the position of Vice President-Finance & Administration at Immune Design Corp.
Mr. Whitmore received an undergraduate degree from the University of California, Santa Barbara.
Eerdere bekende functies van Christopher Whitmore
| Bedrijven | Functie | Einde |
|---|---|---|
| TALPHERA, INC. | Comptroller/Controller/Auditor | 01-04-2015 |
| SANGAMO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-05-2011 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-05-2008 |
| IMMUNE DESIGN CORP | Hoofd Administratief Officier | - |
Opleiding van Christopher Whitmore
| University of California, Santa Barbara | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TALPHERA, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
